Joerg Striessnig

Joerg Striessnig

Universität Innsbruck

H-index: 86

Europe-Austria

About Joerg Striessnig

Joerg Striessnig, With an exceptional h-index of 86 and a recent h-index of 42 (since 2020), a distinguished researcher at Universität Innsbruck, specializes in the field of Ion Channel Pharmacology, Calcium Signaling, Calcium Channels.

His recent articles reflect a diverse array of research interests and contributions to the field:

Novel protocol for multiple-dose oral administration of the L-type Ca2+ channel blocker isradipine in mice: A dose-finding pharmacokinetic study

Pathogenicity of de novo CACNA1D Ca2+ channel variants predicted from sequence co-variation

Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies

The concise guide to PHARMACOLOGY 2023/24: introduction and other protein targets

Phenotype prediction of voltage-gated calcium channel mutations

The Concise Guide to PHARMACOLOGY 2023/24: Ion channels

Voltage-gated Ca2+ Channels: Pharmacology, Modulation and Their Role in Human Disease

Cav1.3‐selective inhibitors of voltage‐gated L‐type Ca2+ channels: Fact or (still) fiction?

Joerg Striessnig Information

University

Universität Innsbruck

Position

Austria

Citations(all)

26503

Citations(since 2020)

7716

Cited By

21867

hIndex(all)

86

hIndex(since 2020)

42

i10Index(all)

196

i10Index(since 2020)

107

Email

University Profile Page

Universität Innsbruck

Joerg Striessnig Skills & Research Interests

Ion Channel Pharmacology

Calcium Signaling

Calcium Channels

Top articles of Joerg Striessnig

Title

Journal

Author(s)

Publication Date

Novel protocol for multiple-dose oral administration of the L-type Ca2+ channel blocker isradipine in mice: A dose-finding pharmacokinetic study

Channels

Tamara Theiner

Nadine J Ortner

Herbert Oberacher

Gospava Stojanovic

Petronel Tuluc

...

2024/12/31

Pathogenicity of de novo CACNA1D Ca2+ channel variants predicted from sequence co-variation

European Journal of Human Genetics

Xuechen Tang

Nadine J Ortner

Yuliia V Nikonishyna

Monica L Fernández-Quintero

Janik Kokot

...

2024/3/29

Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies

Human Molecular Genetics

Ferenc Török

Kamer Tezcan

Ludovica Filippini

Monica L Fernández-Quintero

Lucia Zanetti

...

2023/3/1

The concise guide to PHARMACOLOGY 2023/24: introduction and other protein targets

British journal of pharmacology

Stephen PH Alexander

Eamonn Kelly

Alistair A Mathie

John A Peters

Emma L Veale

...

2023/10

Phenotype prediction of voltage-gated calcium channel mutations

Biophysical Journal

Xuechen Tang

Klaus R Liedl

Monica L Fernandez-Quintero

Joerg Striessnig

2023/2/10

The Concise Guide to PHARMACOLOGY 2023/24: Ion channels

British Journal of Pharmacology

Stephen PH Alexander

Alistair A Mathie

John A Peters

Emma L Veale

Jörg Striessnig

...

2023/10

Voltage-gated Ca2+ Channels: Pharmacology, Modulation and Their Role in Human Disease

Jörg Striessnig

2023/7/31

Cav1.3‐selective inhibitors of voltage‐gated L‐type Ca2+ channels: Fact or (still) fiction?

Ludovica Filippini

Nadine J Ortner

Teresa Kaserer

Jörg Striessnig

2023/5

Voltage-gated calcium channels (CaV) in GtoPdb v.2023.1

IUPHAR/BPS Guide to Pharmacology CITE

William A Catterall

Edward Perez-Reyes

Terrance P Snutch

Jörg Striessnig

2023/4/26

The human channel gating–modifying A749G CACNA1D (Cav1. 3) variant induces a neurodevelopmental syndrome–like phenotype in mice

JCI insight

Nadine J Ortner

Anupam Sah

Enrica Paradiso

Josef Shin

Strahinja Stojanovic

...

2023/10/10

β2-subunit alternative splicing stabilizes Cav2. 3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity

Elife

Anita Siller

Nadja T Hofer

Giulia Tomagra

Nicole Burkert

Simon Hess

...

2022/7/6

Novel CACNA1A Variant p.Cys256Phe Disrupts Disulfide Bonds and Causes Spinocerebellar Ataxia

Movement Disorders

Yuliia V Nikonishyna

Nadine J Ortner

Teresa Kaserer

Jessica Hoffmann

Saskia Biskup

...

2022/2

Separation of the CaV1.2‐CaV1.3 calcium channel duo prevents type 2 allergic airway inflammation

Allergy

Nicolas Giang

Marion Mars

Marc Moreau

Jose E Mejia

Grégory Bouchaud

...

2022/2

Cav1.3 calcium channels are full-range linear amplifiers of firing frequencies in lateral DA SN neurons

Science advances

Josef Shin

Lora Kovacheva

Dominique Thomas

Strahinja Stojanovic

Christopher J Knowlton

...

2022/6/8

Voltage-gated sodium channels (version 2019.4) in the IUPHAR/BPS guide to pharmacology database

William A Catterall

Alan L Goldin

Stephen G Waxman

2022/12/21

Ca2+ Channel Blockers

Jörg Striessnig

Nadine J Ortner

2022/1/7

New CACNA1D missense variants causing a neurodevelopmental disorder show increased dihydropyridine sensitivity

Biophysical Journal

Ferenc Török

Ludovica Filippini

Melissa Mairböck

Anna S Ladstätter

Raphaela S Drexel

...

2022/2/11

Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene CACNA1D Associated with Familial Sinus Node Dysfunction and Focal Idiopathic …

International Journal of Molecular Sciences

Susanne Rinné

Birgit Stallmeyer

Alexandra Pinggera

Michael F Netter

Lina A Matschke

...

2022/11/17

Missense mutations in voltage-gated calcium channels associated with neurodevelopmental and neurodegenerative disorders

Biophysical Journal

Yuliia V Nikonishyna

Nadja T Hofer

Nadine J Ortner

Teresa Kaserer

Jessica Hoffman

...

2022/2/11

Voltage-Gated Ca2+ Channels. Lessons from Knockout and Knock-in Mice

Jörg Striessnig

Akito Nakao

Yasuo Mori

2022/11/8

See List of Professors in Joerg Striessnig University(Universität Innsbruck)

Joerg Striessnig FAQs

What is Joerg Striessnig's h-index at Universität Innsbruck?

The h-index of Joerg Striessnig has been 42 since 2020 and 86 in total.

What are Joerg Striessnig's top articles?

The articles with the titles of

Novel protocol for multiple-dose oral administration of the L-type Ca2+ channel blocker isradipine in mice: A dose-finding pharmacokinetic study

Pathogenicity of de novo CACNA1D Ca2+ channel variants predicted from sequence co-variation

Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies

The concise guide to PHARMACOLOGY 2023/24: introduction and other protein targets

Phenotype prediction of voltage-gated calcium channel mutations

The Concise Guide to PHARMACOLOGY 2023/24: Ion channels

Voltage-gated Ca2+ Channels: Pharmacology, Modulation and Their Role in Human Disease

Cav1.3‐selective inhibitors of voltage‐gated L‐type Ca2+ channels: Fact or (still) fiction?

...

are the top articles of Joerg Striessnig at Universität Innsbruck.

What are Joerg Striessnig's research interests?

The research interests of Joerg Striessnig are: Ion Channel Pharmacology, Calcium Signaling, Calcium Channels

What is Joerg Striessnig's total number of citations?

Joerg Striessnig has 26,503 citations in total.

What are the co-authors of Joerg Striessnig?

The co-authors of Joerg Striessnig are Annette C Dolphin, Tobias Moser, Edward Perez-Reyes, Nicolas Singewald, Thierry Langer, Christoph Romanin.

Co-Authors

H-index: 81
Annette C Dolphin

Annette C Dolphin

University College London

H-index: 75
Tobias Moser

Tobias Moser

Georg-August-Universität Göttingen

H-index: 75
Edward Perez-Reyes

Edward Perez-Reyes

University of Virginia

H-index: 71
Nicolas Singewald

Nicolas Singewald

Universität Innsbruck

H-index: 67
Thierry Langer

Thierry Langer

Universität Wien

H-index: 60
Christoph Romanin

Christoph Romanin

Johannes Kepler Universität Linz

academic-engine